Published Date: April 2023
The report "Global Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method (Surpass Streamline and Other) and Region - Global Forecast to 2029" Global unruptured intracranial aneurysm treatment market is projected to grow from US$ XX billion in 2019 to US$ XX billion by 2029. Unruptured intracranial aneurysm is caused by hemorrhagic stroke which can be so severe that it can lead to coma or even death which in turn is the major driving growth of the global market. In addition, another factor responsible for growth of the global unruptured intracranial aneurysm treatment market is presence of unruptured intracranial aneurysm in the family history. Moreover, increasing healthcare funding by government initiatives is also likely to boost the global market growth. Additionally, high occurrence of high blood pressure in the individuals will also boost growth of the global market. Nevertheless, development of new drugs and advancement in surgical techniques leads to create immerse opportunities for growth of the global market.
Key Highlights:
- On August 2015, Medtronic plc has announced that, it has acquired Medina Medical, a medical device company which focus on commercializing treatments for vascular abnormalities of the brain including cerebral aneurysms. This acquisition has led to an example for company's commitment to its key growth strategy of therapy innovation.
- In June 2019, Medtronic plc, a global leader in medical technology has announced that it has completed its acquisition with Titan Spine. The acquisition between the two companies strengthens Medtronic’s position as a leading innovator in procedural solutions for spine surgery.
Key Market Insights from the report:
The global unruptured intracranial aneurysm treatment market accounted for US$ XX billion in 2019 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented on the basis of technology and region.
- By technology, the global unruptured intracranial aneurysm treatment market is segmented into surpass streamline and other.
- By region, North America dominates the global unruptured intracranial aneurysm treatment market, owing to rising geriatric population, increasing number of screening procedures, presence of leading manufacturers, and technological advancements. Asia Pacific is emerging in terms of global market revenue because of increasing rising population, health care expenditure, and growing awareness.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Unruptured Intracranial Aneurysm Treatment Market”, By Treatment Method (Surpass Streamline and Other) and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2029
The prominent player operating in the global unruptured intracranial aneurysm treatment market includes Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH.
About Prophecy Market Insights
Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount
